Multi-Gene Panel Testing for Hereditary Cancer Predisposition Among Patients Sixty-Five Years and Above Diagnosed With Breast Cancer
GGT should not be overlooked in older BC patients, as this study demonstrates that > 10% of patients have PGVs, largely in potentially actionable genes.
Authors
- Edward D. Esplin (ORCID: https://orcid.org/0000-0001-9205-3756)
- Faris Tamimi (ORCID: https://orcid.org/0000-0002-9337-6618)
- Hikmat Abdel‐Razeq (ORCID: https://orcid.org/0000-0003-2833-6051)
- Sarah M. Nielsen (ORCID: https://orcid.org/0000-0002-5916-6393)
- Rawan Mustafa (ORCID: https://orcid.org/0000-0002-4961-9168)
- Hira Bani Hani (ORCID: https://orcid.org/0009-0001-3604-0886)
- Brandie Heald (ORCID: https://orcid.org/0000-0003-4227-3675)
- Mais Alkyam
- Baha’ Sharaf (ORCID: https://orcid.org/0000-0003-4368-1224)
- Kathryn E. Hatchell (ORCID: https://orcid.org/0000-0003-0849-7018)
- Areej Al-Atary
- Khansa Al‐Azzam
Institutions
- University of Jordan (JO)
- King Hussein Cancer Center (JO)
- Invitae (United States) (US)
Publication Details
- Journal
- World Journal of Oncology
- Published
- 2024-09-23
- DOI
- https://doi.org/10.14740/wjon1919
- Citations
- 1
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.55